| Name | Title | Contact Details |
|---|
Vera Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera`s lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful, including lupus nephritis, a severe renal manifestation of systemic lupus erythematosus.
Embecta will be the name of the independent, publicly-traded company that will hold BD`s Diabetes Care business
Janssen-Ortho Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Advancing RF Technology for the treatment of chronic pain. Nimbus provides a large volume lesion that is cost effective and easy to use.
We provide deep scientific knowledge, global understanding and broad expertise to enhance market access and medical communications for improved health outcomes.